Compagnie Lombard Odier SCmA’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $478K | Buy |
+1,236
| New | +$458K | 0.01% | 226 |
|
|
2025
Q2 | – | Sell |
-2,543
| Closed | -$1.11M | – | 472 |
|
|
2025
Q1 | $1.11M | Buy |
+2,543
| New | +$1.02M | 0.01% | 159 |
|
|
2024
Q1 | – | Sell |
-1,200
| Closed | -$566K | – | 526 |
|
|
2023
Q4 | $566K | Hold |
1,200
| – | – | 0.01% | 209 |
|
|
2023
Q3 | $523K | Buy |
+1,200
| New | +$544K | 0.01% | 184 |
|
|
2023
Q2 | – | Sell |
-2,384
| Closed | -$1.1M | – | 621 |
|
|
2023
Q1 | $1.1M | Buy |
2,384
+947
| +66% | +$451K | 0.03% | 156 |
|
|
2022
Q4 | $738K | Buy |
1,437
+237
| +20% | +$120K | 0.02% | 171 |
|
|
2022
Q3 | $545K | Hold |
1,200
| – | – | 0.02% | 209 |
|
|
2022
Q2 | $579K | Hold |
1,200
| – | – | 0.01% | 192 |
|
|
2022
Q1 | $589K | Hold |
1,200
| – | – | 0.01% | 194 |
|
|
2021
Q4 | $556K | Hold |
1,200
| – | – | 0.01% | 224 |
|
|
2021
Q3 | $447K | Sell |
1,200
-238
| -17% | -$90.4K | 0.01% | 250 |
|
|
2021
Q2 | $549K | Sell |
1,438
-700
| -33% | -$268K | 0.01% | 217 |
|
|
2021
Q1 | $767K | Hold |
2,138
| – | – | 0.02% | 234 |
|
|
2020
Q4 | $686K | Buy |
2,138
+138
| +7% | +$42.4K | 0.02% | 192 |
|
|
2020
Q3 | $537K | Hold |
2,000
| – | – | 0.02% | 189 |
|
|
2020
Q2 | $526K | Sell |
2,000
-100
| -5% | -$26.7K | 0.02% | 186 |
|
|
2020
Q1 | $477K | Buy |
2,100
+1,200
| +133% | +$327K | 0.02% | 181 |
|
|
2019
Q4 | $272K | Sell |
900
-140
| -13% | -$38.5K | 0.01% | 230 |
|
|
2019
Q3 | $250K | Buy |
1,040
+800
| +333% | +$219K | 0.01% | 229 |
|
|
2019
Q2 | $68K | Sell |
240
-5,160
| -96% | -$1.41M | ﹤0.01% | 342 |
|
|
2019
Q1 | $1.55M | Buy |
5,400
+5,300
| +5,300% | +$1.53M | 0.06% | 128 |
|
|
2018
Q4 | $26K | Sell |
100
-1,500
| -94% | -$412K | ﹤0.01% | 433 |
|
|
2018
Q3 | $438K | Hold |
1,600
| – | – | 0.02% | 219 |
|
|
2018
Q2 | $381K | Hold |
1,600
| – | – | 0.01% | 234 |
|
|
2018
Q1 | $352K | Buy |
1,600
+1,467
| +1,103% | +$345K | 0.01% | 247 |
|
|
2017
Q4 | $30K | Buy |
133
+33
| +33% | +$7.03K | ﹤0.01% | 525 |
|
|
2017
Q3 | $19K | Hold |
100
| – | – | ﹤0.01% | 610 |
|
|
2017
Q2 | $19K | Sell |
100
-324
| -76% | -$58.2K | ﹤0.01% | 617 |
|
|
2017
Q1 | $71K | Buy |
424
+31
| +8% | +$4.93K | ﹤0.01% | 494 |
|
|
2016
Q4 | $56K | Hold |
393
| – | – | ﹤0.01% | 595 |
|
|
2016
Q3 | $50K | Hold |
393
| – | – | ﹤0.01% | 679 |
|
|
2016
Q2 | $51K | Buy |
393
+70
| +22% | +$9.58K | ﹤0.01% | 655 |
|
|
2016
Q1 | $45K | Hold |
323
| – | – | ﹤0.01% | 727 |
|
|
2015
Q4 | $45K | Buy |
+323
| New | +$44.5K | ﹤0.01% | 703 |
|
|
2014
Q4 | – | Sell |
-5,514
| Closed | -$660K | – | 791 |
|
|
2014
Q3 | $660K | Sell |
5,514
-67
| -1% | -$7.68K | 0.03% | 263 |
|
|
2014
Q2 | $600K | Sell |
5,581
-1,152
| -17% | -$119K | 0.02% | 283 |
|
|
2014
Q1 | $670K | Buy |
6,733
+375
| +6% | +$33.9K | 0.03% | 271 |
|
|
2013
Q4 | $587K | Buy |
+6,358
| New | +$565K | 0.02% | 290 |
|
Other funds holding ELV
Compagnie Lombard Odier SCmA's ELV Position: Q2 2026 in Review
Compagnie Lombard Odier SCmA opened a new position in Elevance Health (ELV) in Q2 2026: 1,236 shares worth $478K. The stake represents 0.01% of the portfolio and ranks #226 among its holdings. This is a return to the name: Compagnie Lombard Odier SCmA previously reported a position in ELV as recently as Q1 2025.
Compagnie Lombard Odier SCmA first reported a position in ELV in Q4 2013 and has held it in 38 quarters since. The position peaked at $1.55M in Q1 2019. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Compagnie Lombard Odier SCmA held 1,236 shares of Elevance Health worth $478K as of Q2 2026.
- Elevance Health was a new Compagnie Lombard Odier SCmA position in Q2 2026.
- Elevance Health made up 0.01% of Compagnie Lombard Odier SCmA's portfolio in Q2 2026, its #226 holding.
- Compagnie Lombard Odier SCmA first reported a position in Elevance Health in Q4 2013 and has held it in 38 quarters since.
- Compagnie Lombard Odier SCmA's Elevance Health position peaked at $1.55M in Q1 2019.
- 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2026, filed 29 Jul 2026.